Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zasloff

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
European Journal of Biochemistry|March 1, 1995
Functional synergism of the magainins PGLa and magainin-2 in Escherichia coli, tumor cells and liposomesH V Westerhoff, M Zasloff, J L Rosner, et al.
Oncogene|January 13, 2009
The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signalingL Lin, R Amin, G I Gallicano, et al.
Gut|October 30, 2007
NOD2-expressing bone marrow-derived cells appear to regulate epithelial innate immunity of the transplanted human small intestineT Fishbein, G Novitskiy, L Mishra, et al.
Journal of Natural Products|June 8, 2000
Aminosterols from the dogfish shark Squalus acanthiasM N Rao, A E Shinnar, L A Noecker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2001
Squalamine treatment of human tumors in nu/nu mice enhances platinum-based chemotherapiesJ I Williams, S Weitman, C M Gonzalez, et al.
Cancer Research|July 14, 1998
Squalamine inhibits angiogenesis and solid tumor growth in vivo and perturbs embryonic vasculatureA K Sills, J I Williams, B M Tyler, et al.
Oncogene|June 5, 2007
Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular cancer through cyclin D1 activationK Kitisin, N Ganesan, Y Tang, et al.
Oncogene|May 11, 2026
Editorial Expression of Concern: Disruption of transforming growth factor-β signaling through β-spectrin ELF leads to hepatocellular cancer through cyclin D1 activationK Kitisin, N Ganesan, Y Tang, et al.
Genetic Counseling (Geneva, Switzerland)|November 11, 2008
Response to "Mutations of the NOGGIN and of the activin A type I receptor genes in fibrodysplasia ossificans progressiva (FOP)" by Lucotte et alF S Kaplan, M Xu, G Feldman, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
European Journal of Biochemistry|March 1, 1995
Functional synergism of the magainins PGLa and magainin-2 in Escherichia coli, tumor cells and liposomesH V Westerhoff, M Zasloff, J L Rosner, et al.
Oncogene|January 13, 2009
The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signalingL Lin, R Amin, G I Gallicano, et al.
Gut|October 30, 2007
NOD2-expressing bone marrow-derived cells appear to regulate epithelial innate immunity of the transplanted human small intestineT Fishbein, G Novitskiy, L Mishra, et al.
Journal of Natural Products|June 8, 2000
Aminosterols from the dogfish shark Squalus acanthiasM N Rao, A E Shinnar, L A Noecker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2001
Squalamine treatment of human tumors in nu/nu mice enhances platinum-based chemotherapiesJ I Williams, S Weitman, C M Gonzalez, et al.
Cancer Research|July 14, 1998
Squalamine inhibits angiogenesis and solid tumor growth in vivo and perturbs embryonic vasculatureA K Sills, J I Williams, B M Tyler, et al.
Oncogene|June 5, 2007
Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular cancer through cyclin D1 activationK Kitisin, N Ganesan, Y Tang, et al.
Oncogene|May 11, 2026
Editorial Expression of Concern: Disruption of transforming growth factor-β signaling through β-spectrin ELF leads to hepatocellular cancer through cyclin D1 activationK Kitisin, N Ganesan, Y Tang, et al.
Genetic Counseling (Geneva, Switzerland)|November 11, 2008
Response to "Mutations of the NOGGIN and of the activin A type I receptor genes in fibrodysplasia ossificans progressiva (FOP)" by Lucotte et alF S Kaplan, M Xu, G Feldman, et al.
Pageof 10